Description
VIP at 10mg supports extended protocol use — particularly for women following clinical CIRS or mast cell activation protocols where consistent daily VIP administration over 4–8 weeks is indicated. At this dose and duration, the neuroimmune effects of VIP become most apparent: progressive reduction in inflammatory symptoms, improved sleep circadian alignment, and gut motility normalization.
VIP’s circadian role at the SCN makes it synergistic with Pinealon (pineal circadian restoration) and DSIP (delta sleep architecture) for women building comprehensive sleep-circadian correction protocols. For neuroinflammation, it pairs naturally with NAD+ (which reduces neuroinflammatory NF-κB signalling) and Selank (which modulates GABA and BDNF independently of the inflammatory pathway).
Female-calibrated dosing: 50–100mcg intranasally 2–4x daily (clinical CIRS protocol), or 50–100mcg subcutaneously daily for general neuroimmune support. The 10mg vial supports 50–100 doses at 100mcg, covering a complete 4–8 week course.
Storage: Store lyophilized powder below -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.






Reviews
There are no reviews yet.